225 related articles for article (PubMed ID: 19723758)
1. A link between bone mineral density and serum adiponectin and visfatin levels in acromegaly.
Sucunza N; Barahona MJ; Resmini E; Fernández-Real JM; Ricart W; Farrerons J; Rodríguez Espinosa J; Marin AM; Puig T; Webb SM
J Clin Endocrinol Metab; 2009 Oct; 94(10):3889-96. PubMed ID: 19723758
[TBL] [Abstract][Full Text] [Related]
2. Relationships between serum adiponectin, leptin, resistin, visfatin levels and bone mineral density, and bone biochemical markers in Chinese men.
Peng XD; Xie H; Zhao Q; Wu XP; Sun ZQ; Liao EY
Clin Chim Acta; 2008 Jan; 387(1-2):31-5. PubMed ID: 17884030
[TBL] [Abstract][Full Text] [Related]
3. Omentin-1, visfatin and adiponectin levels in relation to bone mineral density in Iranian postmenopausal women.
Tohidi M; Akbarzadeh S; Larijani B; Kalantarhormozi M; Ostovar A; Assadi M; Vahdat K; Farrokhnia M; Sanjdideh Z; Amirinejad R; Nabipour I
Bone; 2012 Nov; 51(5):876-81. PubMed ID: 22971441
[TBL] [Abstract][Full Text] [Related]
4. Adipocytes as a source of increased circulating levels of nicotinamide phosphoribosyltransferase/visfatin in active acromegaly.
Olarescu NC; Ueland T; Lekva T; Dahl TB; Halvorsen B; Aukrust P; Bollerslev J
J Clin Endocrinol Metab; 2012 Apr; 97(4):1355-62. PubMed ID: 22319029
[TBL] [Abstract][Full Text] [Related]
5. Relation of adiponectin, visfatin and bone mineral density in patients with metabolic syndrome.
Iacobellis G; Iorio M; Napoli N; Cotesta D; Zinnamosca L; Marinelli C; Petramala L; Minisola S; D'Erasmo E; Letizia C
J Endocrinol Invest; 2011 Jan; 34(1):e12-5. PubMed ID: 20634640
[TBL] [Abstract][Full Text] [Related]
6. Bone metabolism and body composition in Japanese patients with active acromegaly.
Kaji H; Sugimoto T; Nakaoka D; Okimura Y; Kaji H; Abe H; Chihara K
Clin Endocrinol (Oxf); 2001 Aug; 55(2):175-81. PubMed ID: 11531923
[TBL] [Abstract][Full Text] [Related]
7. Associations between body composition, circulating interleukin-1 receptor antagonist, osteocalcin, and insulin metabolism in active acromegaly.
Ueland T; Fougner SL; Godang K; Lekva T; Schurgers LJ; Scholz H; Halvorsen B; Schreiner T; Aukrust P; Bollerslev J
J Clin Endocrinol Metab; 2010 Jan; 95(1):361-8. PubMed ID: 19880791
[TBL] [Abstract][Full Text] [Related]
8. Gender dimorphism in body composition abnormalities in acromegaly: males are more affected than females.
Sucunza N; Barahona MJ; Resmini E; Fernández-Real JM; Farrerons J; Lluch P; Puig T; Wägner AM; Ricart W; Webb SM
Eur J Endocrinol; 2008 Dec; 159(6):773-9. PubMed ID: 18805912
[TBL] [Abstract][Full Text] [Related]
9. Adipokines in type 1 diabetes after successful pancreas transplantation: normal visfatin and retinol-binding-protein-4, but increased total adiponectin fasting concentrations.
Stadler M; Storka A; Theuer EA; Krebs M; Vojtassakova E; Nowotny P; Pacini G; Kästenbauer T; Luger A; Prager R; Wolzt M; Anderwald C
Clin Endocrinol (Oxf); 2010 Jun; 72(6):763-9. PubMed ID: 19769621
[TBL] [Abstract][Full Text] [Related]
10. Visfatin Levels May be an Early Marker of Atherosclerosis in Patients with Acromegaly.
Piskinpasa H; Okuturlar Y; Dogansen SC; Akdeniz YS; Esen A; Sadri S; Pirhan O; Gemici AA; Serin SO; Gedikbası A; Adas M; Mert M
Horm Metab Res; 2019 Oct; 51(10):649-654. PubMed ID: 31487747
[TBL] [Abstract][Full Text] [Related]
11. Serum visfatin levels in acromegaly: Correlation with disease activity and metabolic alterations.
Ciresi A; Amato MC; Pizzolanti G; Giordano C
Growth Horm IGF Res; 2015 Oct; 25(5):240-6. PubMed ID: 26188992
[TBL] [Abstract][Full Text] [Related]
12. Circulating cytokines in relation to bone mineral density changes in patients with acromegaly.
Bolanowski M; Daroszewski J; Zatonska K; Arkowska A
Neuro Endocrinol Lett; 2006; 27(1-2):183-8. PubMed ID: 16648806
[TBL] [Abstract][Full Text] [Related]
13. The relationship of ghrelin and adiponectin with bone mineral density and bone turnover markers in elderly men.
Gonnelli S; Caffarelli C; Del Santo K; Cadirni A; Guerriero C; Lucani B; Franci B; Nuti R
Calcif Tissue Int; 2008 Jul; 83(1):55-60. PubMed ID: 18563283
[TBL] [Abstract][Full Text] [Related]
14. Relationships between serum adipokines, insulin levels, and bone density in girls with anorexia nervosa.
Misra M; Miller KK; Cord J; Prabhakaran R; Herzog DB; Goldstein M; Katzman DK; Klibanski A
J Clin Endocrinol Metab; 2007 Jun; 92(6):2046-52. PubMed ID: 17356044
[TBL] [Abstract][Full Text] [Related]
15. Insulin resistance, serum visfatin, and adiponectin levels are associated with metabolic disorders in chronic hepatitis C virus-infected patients.
Chen L; Liu W; Lai S; Li Y; Wang X; Zhang H
Eur J Gastroenterol Hepatol; 2013 Aug; 25(8):935-41. PubMed ID: 23470357
[TBL] [Abstract][Full Text] [Related]
16. Interactions between adiponectin, visfatin, and omentin in subcutaneous and visceral adipose tissues and serum, and correlations with clinical and peripheral metabolic factors.
Sitticharoon C; Nway NC; Chatree S; Churintaraphan M; Boonpuan P; Maikaew P
Peptides; 2014 Dec; 62():164-75. PubMed ID: 25453978
[TBL] [Abstract][Full Text] [Related]
17. Relationships between serum adiponectin, apelin, leptin, resistin, visfatin levels and bone mineral density, and bone biochemical markers in post-menopausal Chinese women.
Zhang H; Xie H; Zhao Q; Xie GQ; Wu XP; Liao EY; Luo XH
J Endocrinol Invest; 2010 Nov; 33(10):707-11. PubMed ID: 20208458
[TBL] [Abstract][Full Text] [Related]
18. Serum visfatin concentration and endothelial dysfunction in chronic kidney disease.
Yilmaz MI; Saglam M; Carrero JJ; Qureshi AR; Caglar K; Eyileten T; Sonmez A; Cakir E; Yenicesu M; Lindholm B; Stenvinkel P; Axelsson J
Nephrol Dial Transplant; 2008 Mar; 23(3):959-65. PubMed ID: 17984105
[TBL] [Abstract][Full Text] [Related]
19. Circulating visfatin in obese non-diabetic patients in relation to cardiovascular risk factors, insulin resistance, and adipocytokines: a contradictory piece of the puzzle.
de Luis DA; Sagrado MG; Aller R; Conde R; Izaola O
Nutrition; 2010; 26(11-12):1130-3. PubMed ID: 19211226
[TBL] [Abstract][Full Text] [Related]
20. Elevated serum visfatin/nicotinamide phosphoribosyl-transferase levels are associated with risk of postmenopausal breast cancer independently from adiponectin, leptin, and anthropometric and metabolic parameters.
Dalamaga M; Karmaniolas K; Papadavid E; Pelekanos N; Sotiropoulos G; Lekka A
Menopause; 2011 Nov; 18(11):1198-204. PubMed ID: 21712732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
